First long-acting injectable treatment for HIV represents an exciting step forward, should be optimized with equity, investment Dr. Rajesh Gandhi is the Co-Director of the Harvard Center for AIDS Research and the site leader of the MGH Clinical Research Site in the Harvard/Miriam AIDS Clinical Trials Unit and a scientific member of the Department of […]
Innovative approaches can help find vulnerable young women in need of HIV prevention services The following is a guest post by Michelle Li, MS, and Quinn Lewis, MIA, of Data.FI project In sub-Saharan Africa, adolescent girls and young women are disproportionately impacted by HIV and are more likely to become infected, compared to their male […]
The following is a guest post by Richard Ngethe, MBA, and Jonathan Friedman, MS According to a study by UNAIDS of Brazil, of an estimated 140 million records in the national user database—including all health records—only 100 million unique patients were represented. The number of patients, therefore, was overstated by 40%.[1] This is the kind […]
The following is a guest post by Cathy Cantelmo, Rebecca Ross, Shree Prabhakaran and Arin Dutta Indonesia has not yet achieved UNAIDS 90-90-90 HIV treatment targets or epidemic control. Of the people living with HIV as of June 2020, only 63 percent knew their status, just a quarter were on antiretroviral therapy, and a mere […]
The following is a guest post by Tyra Fom of Data.FI The COVID-19 pandemic poses a double threat for people living with HIV, who must find ways during lockdown to access their antiretroviral therapy from overwhelmed health facilities. In addition, people who have the virus but are not yet diagnosed face challenges getting tested and […]
By Dr. Vincent Guilamo-Ramos and Dr. Barbara Taylor In February 2019, the federal government updated national HIV goals to end the epidemic in the U.S. by 2030. Those goals appeared to be coming into reach because of significant overall progress in the fight against HIV, with deaths attributed to HIV across the U.S. decreasing by approximately 4% […]
Dr. Vincent Guilamo-Ramos is the vice-chair of the board of directors of the Latino Commission on AIDS, and director and founder of the Center for Latino Adolescent and Family Health and the co-chair of the Ending the HIV Epidemic working group for the HIV Medicine Association, which produces this blog. Today, on National Latinx AIDS […]
The following is a guest post by Serge Bisore, MPH and Hypax Mbanye, MA, of Data.FI Using data to improve performance is challenging when the quality of the data is uneven. As we move towards epidemic control, national AIDS control programs and ministries of health need complete, timely, and accurate information on HIV indicators so […]
Thirty years ago this week Congress passed the Ryan White Comprehensive AIDS Resources Emergency Act, named for the young man who stood up to stigma and discrimination before losing his life to the virus in 1990. The legislation, launching a program that addresses obstacles to consistent and effective HIV care confronting communities hardest hit by […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]